Spots Global Cancer Trial Database for eye
Every month we try and update this database with for eye cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Preliminary Study on Eye Features of Patients With Malignant Tumors | NCT04224298 | Feature Elongat... Cancer Patients | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | ||
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life | NCT00639301 | Retinoblastoma | Questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma | NCT00387023 | Non-Hodgkin's L... Lymphoma | Rituximab Zevalin | 18 Years - | M.D. Anderson Cancer Center | |
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life | NCT00639301 | Retinoblastoma | Questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Treatment With Intravitreal Avastin for Large Uveal Melanomas | NCT00596362 | Uveal Melanoma | AVASTIN | 18 Years - | Memorial Sloan Kettering Cancer Center | |
MRI in Diagnosing Solid Tumors of the Eye and Orbit | NCT01653080 | Eye Cancer | dynamic contras... | 18 Years - | University of Cincinnati | |
Treatment With Intravitreal Avastin for Large Uveal Melanomas | NCT00596362 | Uveal Melanoma | AVASTIN | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Validation of a Molecular Prognostic Test for Eye Melanoma | NCT00406120 | Uveal Neoplasms Choroid Neoplas... Iris Neoplasms | Fine needle asp... | - | Washington University School of Medicine | |
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations | NCT05199584 | Solid Tumors Wi... | ENV-101 (talade... | 18 Years - | Endeavor Biomedicines, Inc. | |
Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage | NCT01393769 | Retinoblastoma | Melphalan | 6 Months - 6 Years | Hospital Sant Joan de Deu | |
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life | NCT00639301 | Retinoblastoma | Questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma | NCT01252251 | Uveal Melanoma | RAD001 (Everoli... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Validation of a Molecular Prognostic Test for Eye Melanoma | NCT00406120 | Uveal Neoplasms Choroid Neoplas... Iris Neoplasms | Fine needle asp... | - | Washington University School of Medicine | |
MRI in Diagnosing Solid Tumors of the Eye and Orbit | NCT01653080 | Eye Cancer | dynamic contras... | 18 Years - | University of Cincinnati |